IL309796A - Bifunctional compounds for BTK degradation with reduced IMID activity - Google Patents

Bifunctional compounds for BTK degradation with reduced IMID activity

Info

Publication number
IL309796A
IL309796A IL309796A IL30979623A IL309796A IL 309796 A IL309796 A IL 309796A IL 309796 A IL309796 A IL 309796A IL 30979623 A IL30979623 A IL 30979623A IL 309796 A IL309796 A IL 309796A
Authority
IL
Israel
Prior art keywords
imid
diminished
activity
bifunctional compounds
btk
Prior art date
Application number
IL309796A
Other languages
English (en)
Hebrew (he)
Inventor
Cristiana Guiducci
Mark Noviski
Janine Powers
Ryan Rountree
Ying Siow Tan
Original Assignee
Nurix Therapeutics Inc
Cristiana Guiducci
Mark Noviski
Janine Powers
Ryan Rountree
Ying Siow Tan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nurix Therapeutics Inc, Cristiana Guiducci, Mark Noviski, Janine Powers, Ryan Rountree, Ying Siow Tan filed Critical Nurix Therapeutics Inc
Publication of IL309796A publication Critical patent/IL309796A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL309796A 2021-07-14 2022-07-13 Bifunctional compounds for BTK degradation with reduced IMID activity IL309796A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163221905P 2021-07-14 2021-07-14
PCT/US2022/037029 WO2023287928A1 (en) 2021-07-14 2022-07-13 Bifunctional compounds for degrading btk with diminished imid activity

Publications (1)

Publication Number Publication Date
IL309796A true IL309796A (en) 2024-02-01

Family

ID=82799901

Family Applications (1)

Application Number Title Priority Date Filing Date
IL309796A IL309796A (en) 2021-07-14 2022-07-13 Bifunctional compounds for BTK degradation with reduced IMID activity

Country Status (9)

Country Link
US (1) US20240336595A1 (cg-RX-API-DMAC7.html)
EP (1) EP4370123A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024525797A (cg-RX-API-DMAC7.html)
KR (1) KR20240035837A (cg-RX-API-DMAC7.html)
CN (1) CN118019538A (cg-RX-API-DMAC7.html)
AU (1) AU2022310182A1 (cg-RX-API-DMAC7.html)
CA (1) CA3225367A1 (cg-RX-API-DMAC7.html)
IL (1) IL309796A (cg-RX-API-DMAC7.html)
WO (1) WO2023287928A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3867242A1 (en) 2018-10-15 2021-08-25 Nurix Therapeutics, Inc. Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
EP3924350A1 (en) 2019-02-13 2021-12-22 Nurix Therapeutics, Inc. Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
CA3160713A1 (en) 2019-12-04 2021-06-10 Nurix Therapeutics, Inc. Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
KR20240029070A (ko) * 2021-07-01 2024-03-05 항저우 힐젠 테라퓨틱스 컴퍼니 리미티드 브루톤 티로신 키나아제, 이의 돌연변이체 분해제, 조성물 및 응용
MX2024004899A (es) 2021-10-26 2024-05-24 Nurix Therapeutics Inc Compuestos de piperidinilpirazina-carboxamida para tratar y prevenir el cancer y para degradar btk.
WO2025162210A1 (zh) * 2024-02-04 2025-08-07 上海超阳药业有限公司 一种具备降解酪氨酸蛋白激酶btk活性的化合物及其制备方法和用途
TW202606657A (zh) * 2024-06-27 2026-02-16 南韓商韓美藥品股份有限公司 新型異雙功能蛋白質降解劑以及包含其的藥物組成物
CN120590386A (zh) * 2025-05-30 2025-09-05 北京科莱博医药开发有限责任公司 一种喹喔啉类蛋白降解剂及其制备方法和应用
CN120617259B (zh) * 2025-06-05 2026-04-10 南昌大学第一附属医院 Btk protac化合物nx-5948的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3867242A1 (en) 2018-10-15 2021-08-25 Nurix Therapeutics, Inc. Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
CA3160713A1 (en) 2019-12-04 2021-06-10 Nurix Therapeutics, Inc. Bifunctional compounds for degrading btk via ubiquitin proteosome pathway

Also Published As

Publication number Publication date
KR20240035837A (ko) 2024-03-18
CA3225367A1 (en) 2023-01-19
EP4370123A1 (en) 2024-05-22
CN118019538A (zh) 2024-05-10
AU2022310182A1 (en) 2024-02-01
JP2024525797A (ja) 2024-07-12
WO2023287928A1 (en) 2023-01-19
US20240336595A1 (en) 2024-10-10

Similar Documents

Publication Publication Date Title
HUE072392T2 (hu) Bifunkcionális vegyületek a BTK bontására az ubikvitin proteoszóma útvonalon keresztül
IL279256A (en) Sulfonimidamide compounds as inhibitors of interleukin-1 activity
SG11202012159TA (en) Sulfonylurea compounds as inhibitors of interleukin-1 activity
IL283191A (en) Dynamic carrier subband operation for active coordination sets
GB202020191D0 (en) Pharmaceutical compounds
GB2602378B (en) Lid subsystem for media processing devices
PT4172114T (pt) Uso de um portador de biofilme para reatores de biofilme de leito móvel
GB202010408D0 (en) Pharmaceutical compounds
IL288210B2 (en) Dosing regimens of IL-2/IL-15 beta-gamma receptor agonists for the treatment of cancer or infectious diseases
IL279698A (en) Compounds that increase proteasome activity
IL285825A (en) A system for disabling a medical robot
IL311729A (en) Processes for preparing a macrocyclic compound having ent1 inhibiting activity
PL4309933T3 (pl) Zespół osłony do skrzyni ładunkowej samochodów ciężarowych
ZA202200897B (en) Fluidized bed reactor system allowing particle sampling during an ongoing reaction
HK40111864A (en) Bifunctional compounds for degrading btk with diminished imid activity
HK40112047A (en) Bifunctional compounds for degrading btk with enhanced imid activity
GB202308214D0 (en) Support tools for autonomous vehichles
IL326231A (en) Carboxamide-4-quinoline compounds with anthelmintic activity
CA200891S (en) Bed
GB202319376D0 (en) Compounds with animicrobial activity
GB202004030D0 (en) A nursing-type infant bed for preventing accidental fall
CA211584S (en) Film-dispensing cassette for garbage
GB202211892D0 (en) An activity device
GB202215058D0 (en) Compounds for use as medicaments
CA3298056A1 (en) Carboxamide-4-quinoline compounds with anthelmintic activity